A novel clinically relevant animal model for studying galectin-3 and its ligands during colon carcinogenesis

Journal of Histochemistry and Cytochemistry

Volumn 58, Issue 6, 2010, Pages 553-565

  Hill, Marcelo ^a   Mazal, Daniel ^b   Biron, Verónica Andrea ^d   Pereira, Laura ^b   Ubillos, Luis ^b   Berriel, Edgardo ^c   Ahmed, Hafiz ^e   Freire, Teresa ^b   Rondán, Mariella ^b   Vasta, Gerardo R ^e   Liu, Fu Tong ^f   Iglesias, María Mercedes ^d   Osinaga, Eduardo ^b,g  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^c Hospital Pasteur Montevideo   (Uruguay)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^e UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g INSTITUT PASTEUR DE MONTEVIDEO   (Uruguay)

Author keywords

Animal models; Carcinogenesis; Colon cancer; Galectin 3

Indexed keywords

1,2 DIMETHYLHYDRAZINE; GALECTIN 3; MONOCLONAL ANTIBODY; SERINE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE TARGETING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA; RATTUS;

EID: 77952762068     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2010.955237     Document Type: Article

References (57)

1. Abdel-Aziz HO, Murai Y, Takasaki I, Tabuchi Y, Zheng HC, Nomoto K, Takahashi H, et al. (2008) Targeted disruption of the galectin-3 gene results in decreased susceptibility to NNK-induced lung tumorigenesis: an oligonucleotide microarray study. J Cancer Res Clin Oncol 134:777-788
2. Ahmed H, Banerjee PP, Vasta GR (2007) Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter methylation. Biochem Biophys Res Commun 358:241-246 (Pubitemid 46719109)
3. Ahmed H, Bianchet MA, Amzel LM, Hirabayashi J, Kasai K, Giga-Hama Y, Tohda H, et al. (2002) Novel carbohydrate specificity of the 16-kDa galectin from Caenorhabditis elegans: binding to blood group precursor oligosaccharides (type 1, type 2, Talpha, and Tbeta) and gangliosides. Glycobiology 12:451-461
4. Ahmed H, Pohl J, Fink NE, Strobel F, Vasta GR (1996) The primary structure and carbohydrate specificity of a beta-galactosyl-binding lectin from toad (Bufo arenarum Hensel) ovary reveal closer similarities to the mammalian galectin-1 than to the galectin from the clawed frog Xenopus laevis. J Biol Chem 271:33083-33094 (Pubitemid 27008748)
5. Allegrucci C, Liguori L, Minelli A (2001) Stimulation by N6-cyclopentyladenosine of A1 adenosine receptors, coupled to galphai2 protein subunit, has a capacitative effect on human spermatozoa. Biol Reprod 64:1653-1659 (Pubitemid 32493480)
6. Amberger H (1986) Different autochthonous models of colorectal cancer in the rat. J Cancer Res Clin Oncol 111:157-159
7. Bachhawat-Sikder K, Thomas CJ, Surolia A (2001) Thermodynamic analysis of the binding of galactose and poly-N-acetyllactosamine derivatives to human galectin-3. FEBS Lett 500:75-79 (Pubitemid 32575322)
8. Berriel E, Hill M, Barcia JJ, Ubillos L, Gonzalez M, Detjen G, Rondan M, et al. (2005) Simple mucin-type cancer associated antigens are pre-cancerous biomarkers during 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Oncol Rep 14:219-227
9. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
10. Bresalier RS, Mazurek N, Sternberg LR, Byrd JC, Yunker CK, Nangia-Makker P, Raz A (1998) Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. Gastroenterology 115:287-296 (Pubitemid 28363421)
11. Brustle B, Kreissl S, Mykles DL, Rathmayer W (2001) The neuropeptide proctolin induces phosphorylation of a 30 kDa protein associated with the thin filament in crustacean muscle. J Exp Biol 204:2627-2635 (Pubitemid 34861400)
12. Byrd JC, Bresalier RS (2004) Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 23:77-99
13. Califice S, Castronovo V, Van Den Brûle F (2004) Galectin-3 and cancer. Int J Oncol 25:983-992
14. Chang WW (1984) Histogenesis of colon cancer in experimental animals. Scand J Gastroenterol Suppl 104:27-43 (Pubitemid 15191683)
15. Dagher SF, Wang JL, Patterson RJ (1995) Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci USA 92:1213-1217
16. Demetter P, Nagy N, Martin B, Mathieu A, Dumont P, Decaestecker C, Salmon I (2008) The galectin family and digestive disease. J Pathol 215:1-12
17. Endo K, Kohnoe S, Tsujita E, Watanabe A, Nakashima H, Baba H, Maehara Y (2005) Galectin-3 expression is a potent prognostic marker in colorectal cancer. Anticancer Res 25:3117-3121 (Pubitemid 41044709)
18. Eude-Le Parco I, Gendronneau G, Dang T, Delacour D, Thijssen VL, Edelmann W, Peuchmaur M, et al. (2009) Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice. Glycobiology 19:68-75
19. Fukumori T, Oka N, Takenaka Y, Nangia-Makker P, Elsamman E, Kasai T, Shono M, et al. (2006) Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer. Cancer Res 66:3114-3119
20. Hallouin F, Goupille C, le Cabellec M, Bara J, le Pendu J (1997) Expression of A and H blood-group and of CD44 antigens during chemical rat colonic carcinogenesis. Glycoconj J 14:801-808 (Pubitemid 27514325)
21. Hamilton S, Aaltonen L (2000) WHO Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon, France, IARC Press, 103-143
22. Hittelet A, Legendre H, Nagy N, Bronckart Y, Pector JC, Salmon I, Yeaton P, et al. (2003) Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration. Int J Cancer 103:370-379 (Pubitemid 36076430)
23. Ho MK, Springer TA (1982) Mac-1 antigen: quantitative expression in macrophage populations and tissues, and immunofluorescent localization in spleen. J Immunol 128:2281-2286
24. Hsu DK, Yang RY, Liu FT (2006) Galectins in apoptosis. Methods Enzymol 417:256-273
25. Huflejt ME, Turck CW, Lindstedt R, Barondes SH, Leffler H (1993) L-29, a soluble lactose-binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase I. J Biol Chem 268:26712-26718 (Pubitemid 23361758)
26. Hughes RC (2001) Galectins as modulators of cell adhesion. Biochimie 83:667-676
27. Irimura T, Matsushita Y, Sutton RC, Carralero D, Ohannesian DW, Cleary KR, Ota DM, et al. (1991) Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. Cancer Res 51:387-393
28. Koesters R, Hans MA, Benner A, Prosst R, Boehm J, Gahlen J, Doeberitz MK (2001) Predominant mutation of codon 41 of the beta-catenin proto-oncogene in rat colon tumors induced by 1,2-dimethylhydrazine using a complete carcinogenic protocol. Carcinogenesis 22:1885-1890 (Pubitemid 33064856)
29. Labarriere N, Piau JP, Otry C, Denis M, Lustenberger P, Meflah K, Le Pendu J (1994) H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells. Cancer Res 54:6275-6281 (Pubitemid 24378665)
30. Legendre H, Decaestecker C, Nagy N, Hendlisz A, Schuring MP, Salmon I, Gabius HJ, et al. (2003) Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers. Mod Pathol 16:491-504 (Pubitemid 36618470)
31. Lin HM, Pestell RG, Raz A, Kim HR (2002) Galectin-3 enhances cyclin D(1) promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells. Oncogene 21:8001-8010 (Pubitemid 35430611)
32. Liu FT, Hsu DK, Zuberi RI, Hill PN, Shenhav A, Kuwabara I, Chen SS (1996) Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domains. Biochemistry 35:6073-6079 (Pubitemid 26147579)
33. Liu FT, Rabinovich GA (2005) Galectins as modulators of tumour progression. Nat Rev Cancer 5:29-41
34. Liu YF, Paz K, Herschkovitz A, Alt A, Tennenbaum T, Sampson SR, Ohba M, et al. (2001) Insulin stimulates PKCzeta-mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J Biol Chem 276:14459-14465 (Pubitemid 37391839)
35. Lotz MM, Andrews CW Jr, Korzelius CA, Lee EC, Steele GD Jr, Clarke A, Mercurio AM (1993) Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci USA 90:3466-3470 (Pubitemid 23111387)
36. Mazurek N, Conklin J, Byrd JC, Raz A, Bresalier RS (2000) Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands. J Biol Chem 275:36311-36315
37. Mazurek N, Sun YJ, Price JE, Ramdas L, Schober W, Nangia-Makker P, Byrd JC, et al. (2005) Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes. Cancer Res 65:10767-10775 (Pubitemid 41713345)
38. Nagy N, Legendre H, Engels O, Andre S, Kaltner H, Wasano K, Zick Y, et al. (2003) Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting. Cancer 97:1849-1858 (Pubitemid 36397258)
39. Nakahara S, Raz A (2008) Biological modulation by lectins and their ligands in tumor progression and metastasis. Anticancer Agents Med Chem 8:22-36
40. Nakamura M, Inufusa H, Adachi T, Aga M, Kurimoto M, Nakatani Y, Wakano T, et al. (1999) Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol 15:143-148
41. Naz RK (1999) Involvement of protein serine and threonine phosphorylation in human sperm capacitation. Biol Reprod 60:1402-1409
42. Orlando FA, Tan D, Baltodano JD, Khoury T, Gibbs JF, Hassid VJ, Ahmed BH, et al. (2008) Aberrant crypt foci as precursors in colorectal cancer progression. J Surg Oncol 98:207-213
43. Rabinovich GA, Baum LG, Tinari N, Paganelli R, Natoli C, Liu FT, Iacobelli S (2002) Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol 23:313-320
44. Sanjuan X, Fernandez PL, Castells A, Castronovo V, van den Brule F, Liu FT, Cardesa A, et al. (1997) Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology 113:1906-1915
45. Saussez S, Nonclercq D, Laurent G, Wattiez R, Andre S, Kaltner H, Gabius HJ, et al. (2005) Toward functional glycomics by localization of tissue lectins: immunohistochemical galectin fingerprinting during diethylstilbestrol-induced kidney tumorigenesis in male Syrian hamster. Histochem Cell Biol 123:29-41
46. Schoeppner HL, Raz A, Ho SB, Bresalier RS (1995) Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer 75:2818-2826
47. Schwartz B, Avivi C, Lamprecht SA (1991) Isolation and characterization of normal and neoplastic colonic epithelial cell populations. Gastroenterology 100:692-702
48. Schwartz B, Benharroch D, Prinsloo I, Cagnano E, Lamprecht SA (1995) Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis. Anticancer Res 15:211-218
49. Shimura T, Takenaka Y, Tsutsumi S, Hogan V, Kikuchi A, Raz A (2004) Galectin-3, a novel binding partner of beta-catenin. Cancer Res 64:6363-6367
50. Takenaka Y, Fukumori T, Yoshii T, Oka N, Inohara H, Kim HR, Bresalier RS, et al. (2004) Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs. Mol Cell Biol 24:4395-4406
51. van den Brûle F, Califice S, Castronovo V (2004) Expression of galectins in cancer: a critical review. Glycoconj J 19:537-542
52. van den Brûle FA, Waltregny D, Liu FT, Castronovo V (2000) Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression. Int J Cancer 89:361-367
53. Vlahovic G, Crawford J (2003) Activation of tyrosine kinases in cancer. Oncologist 8:531-538
54. Vuillier F, Scott-Algara D, Cayota A, Siciliano J, Nugeyre MT, Dighiero G (1995) Flow cytometric analysis of protein-tyrosine phosphorylation in peripheral T cell subsets. Application to healthy and HIV-seropositive subjects. J Immunol Methods 85:43-56
55. Yamazaki K, Kawai A, Kawaguchi M, Hibino Y, Li F, Sasahara M, Tsukada K, et al. (2001) Simultaneous induction of galectin-3 phosphorylated on tyrosine residue, p21(WAF1/Cip1/Sdi1), and the proliferating cell nuclear antigen at a distinctive period of repair of hepatocytes injured by CCl4. Biochem Biophys Res Commun 280:1077-1084
56. Yang RY, Rabinovich GA, Liu FT (2008) Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 10:e17
57. Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim HR, Raz A (2002) Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem 277:6852-6857 (Pubitemid 34953068)